Search research articles
Contact Us
Filters
Showing results (31-40 of 164) with videos related to
Page
of 17
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 24, 1998
[Postmenopausal hormonal substitution and risk of venous thromboembolism. Need for prospective, randomized trials]
H Arnesen, E Qvigstad
Journal of the Oslo City Hospitals
|
September 1, 1985
Primary ventricular fibrillation complicating acute myocardial infarction: incidence in subgroups
O Skjaeggestad, H Arnesen
Scandinavian Journal of Clinical and Laboratory Investigation
|
May 1, 1972
2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase
H Arnesen, M K Fagerhol
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
August 30, 1972
[Simple routine method for fibrinogen determination]
H Arnesen, H C Godal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
September 28, 1998
[Peroral anticoagulant therapy]
H Arnesen, P M Sandset
Scandinavian Journal of Haematology
|
January 1, 1973
Studies on the thrombin clotting time. I. The influence of fibrinogen degradation products
H Arnesen, H C Godal
Thrombosis Research
|
September 6, 2000
Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin
M Hurlen, I Seljeflot, H Arnesen
Journal of Thrombosis and Haemostasis : JTH
|
April 22, 2004
Increased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarction
I Seljeflot, M Hurlen, H Arnesen
Acta Medica Scandinavica
|
January 1, 1980
Plasma free fatty acids and the incidence of arrhythmias in acute myocardial infarction during treatment with small doses of subcutaneous heparin or warfarin
H Arnesen, O Skjaeggestad, B Wik
Acta Medica Scandinavica
|
January 1, 1981
Hyperlipoproteinaemia and reduced fibrinolytic activity in healthy coronary high-risk men
P Andersen, H Arnesen, I Hjermann
Page
of 17
Search research articles
Search
Showing results (31-40 of 164) with videos related to
Sort By:
Page
of 17
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 24, 1998
[Postmenopausal hormonal substitution and risk of venous thromboembolism. Need for prospective, randomized trials]
H Arnesen, E Qvigstad
Journal of the Oslo City Hospitals
|
September 1, 1985
Primary ventricular fibrillation complicating acute myocardial infarction: incidence in subgroups
O Skjaeggestad, H Arnesen
Scandinavian Journal of Clinical and Laboratory Investigation
|
May 1, 1972
2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase
H Arnesen, M K Fagerhol
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
August 30, 1972
[Simple routine method for fibrinogen determination]
H Arnesen, H C Godal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
September 28, 1998
[Peroral anticoagulant therapy]
H Arnesen, P M Sandset
Scandinavian Journal of Haematology
|
January 1, 1973
Studies on the thrombin clotting time. I. The influence of fibrinogen degradation products
H Arnesen, H C Godal
Thrombosis Research
|
September 6, 2000
Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin
M Hurlen, I Seljeflot, H Arnesen
Journal of Thrombosis and Haemostasis : JTH
|
April 22, 2004
Increased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarction
I Seljeflot, M Hurlen, H Arnesen
Acta Medica Scandinavica
|
January 1, 1980
Plasma free fatty acids and the incidence of arrhythmias in acute myocardial infarction during treatment with small doses of subcutaneous heparin or warfarin
H Arnesen, O Skjaeggestad, B Wik
Acta Medica Scandinavica
|
January 1, 1981
Hyperlipoproteinaemia and reduced fibrinolytic activity in healthy coronary high-risk men
P Andersen, H Arnesen, I Hjermann
Page
of 17